BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 35397928)

  • 1. Prediction of Microvascular Invasion in Combined Hepatocellular-Cholangiocarcinoma Based on Pre-operative Clinical Data and Contrast-Enhanced Ultrasound Characteristics.
    Chen Y; Lu Q; Zhu Y; Huang B; Dong Y; Wang W
    Ultrasound Med Biol; 2022 Jul; 48(7):1190-1201. PubMed ID: 35397928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined hepatocellular-cholangiocarcinoma: which preoperative clinical data and conventional MRI characteristics have value for the prediction of microvascular invasion and clinical significance?
    Wang X; Wang W; Ma X; Lu X; Li S; Zeng M; Xu K; Yang C
    Eur Radiol; 2020 Oct; 30(10):5337-5347. PubMed ID: 32385649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of microvascular invasion in combined hepatocellular-cholangiocarcinoma based on preoperative contrast-enhanced CT and clinical data.
    Zhang J; Dong W; Li Y; Fu J; Jia N
    Eur J Radiol; 2023 Jun; 163():110839. PubMed ID: 37121101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative evaluation of MRI features and inflammatory biomarkers in predicting microvascular invasion of combined hepatocellular cholangiocarcinoma.
    Zhang J; Dong W; Liu W; Fu J; Liao T; Li Y; Huo L; Jia N
    Abdom Radiol (NY); 2024 Mar; 49(3):710-721. PubMed ID: 38112787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of CEUS LI-RADS and serum tumor markers for combined hepatocellular-cholangiocarcinoma.
    Wen R; Lin P; Wu Y; Yin H; Huang W; Guo D; Peng Y; Liu D; He Y; Yang H
    Eur J Radiol; 2022 Sep; 154():110415. PubMed ID: 35738166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential diagnostic performance of contrast-enhanced ultrasound and tumor markers in differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma.
    Huang XW; Huang Y; Chen LD; Wang Z; Yang Z; Liu JY; Xie XY; Lu MD; Shen SL; Wang W
    J Med Ultrason (2001); 2018 Apr; 45(2):231-241. PubMed ID: 29052791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applications of Dynamic Contrast-Enhanced Ultrasound in Differential Diagnosis of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma in Non-cirrhotic Liver.
    Dong Y; Chen S; Möller K; Qiu YJ; Lu XY; Zhang Q; Dietrich CF; Wang WP
    Ultrasound Med Biol; 2023 Aug; 49(8):1780-1788. PubMed ID: 37156676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast-Enhanced Ultrasound-Based Nomogram: A Potential Predictor of Individually Postoperative Early Recurrence for Patients With Combined Hepatocellular-Cholangiocarcinoma.
    Guo HL; Lu XZ; Hu HT; Ruan SM; Zheng X; Xie XY; Lu MD; Kuang M; Shen SL; Chen LD; Wang W
    J Ultrasound Med; 2022 Aug; 41(8):1925-1938. PubMed ID: 34751450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive factors of microvascular invasion in patients with intrahepatic mass-forming cholangiocarcinoma based on magnetic resonance images.
    Chen S; Wan L; Zhao R; Peng W; Li Z; Zou S; Zhang H
    Abdom Radiol (NY); 2023 Apr; 48(4):1306-1319. PubMed ID: 36872324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using immunovascular characteristics to predict very early recurrence and prognosis of resectable intrahepatic cholangiocarcinoma.
    Xu Y; Li Z; Zhou Y; Yang Y; Ouyang J; Li L; Huang Z; Ye F; Ying J; Zhao H; Zhou J; Zhao X
    BMC Cancer; 2023 Oct; 23(1):1009. PubMed ID: 37858111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nomogram based on preoperative clinical and MRI features to estimate the microvascular invasion status and the prognosis of solitary intrahepatic mass-forming cholangiocarcinoma.
    Chen S; Wan L; Zhao R; Peng W; Liu X; Li L; Zhang H
    Abdom Radiol (NY); 2024 Feb; 49(2):425-436. PubMed ID: 37889266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Sonazoid contrast-enhanced ultrasound for predicting the risk of microvascular invasion in hepatocellular carcinoma: a prospective multicenter study.
    Yao J; Li K; Yang H; Lu S; Ding H; Luo Y; Li K; Xie X; Wu W; Jing X; Liu F; Yu J; Cheng Z; Tan S; Dou J; Dong X; Wang S; Zhang Y; Li Y; Qi E; Han Z; Liang P; Yu X
    Eur Radiol; 2023 Oct; 33(10):7066-7076. PubMed ID: 37115213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast-enhanced ultrasound in association with serum biomarkers for differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
    Yang J; Zhang YH; Li JW; Shi YY; Huang JY; Luo Y; Liu JB; Lu Q
    World J Gastroenterol; 2020 Dec; 26(46):7325-7337. PubMed ID: 33362387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of mass-forming intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma: based on the multivariate analysis of contrast-enhanced computed tomography findings.
    Zhao YJ; Chen WX; Wu DS; Zhang WY; Zheng LR
    Abdom Radiol (NY); 2016 May; 41(5):978-89. PubMed ID: 27193795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI features predict microvascular invasion in intrahepatic cholangiocarcinoma.
    Ma X; Liu L; Fang J; Rao S; Lv L; Zeng M; Shi Y; Yang C
    Cancer Imaging; 2020 Jun; 20(1):40. PubMed ID: 32576283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A nomogram based on multi-modal ultrasound for prediction of microvascular invasion and recurrence of hepatocellular carcinoma.
    Zhong X; Peng J; Xie Y; Shi Y; Long H; Su L; Duan Y; Xie X; Lin M
    Eur J Radiol; 2022 Jun; 151():110281. PubMed ID: 35395542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mass-forming intrahepatic cholangiocarcinoma: Can diffusion-weighted imaging predict microvascular invasion?
    Zhou Y; Wang X; Xu C; Zhou G; Liu X; Gao S; Xu P
    J Magn Reson Imaging; 2019 Jul; 50(1):315-324. PubMed ID: 30444023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study on correlation between two-dimensional ultrasound, contrast-enhanced ultrasound and microvascular invasion in hepatocellular carcinoma.
    Wang P; Nie F; Dong T; Wang G; Wang L; Fan X
    Clin Hemorheol Microcirc; 2022; 80(2):97-106. PubMed ID: 34057142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation of intrahepatic cholangiocarcinoma from hepatocellular carcinoma in high-risk patients: A predictive model using contrast-enhanced ultrasound.
    Chen LD; Ruan SM; Liang JY; Yang Z; Shen SL; Huang Y; Li W; Wang Z; Xie XY; Lu MD; Kuang M; Wang W
    World J Gastroenterol; 2018 Sep; 24(33):3786-3798. PubMed ID: 30197484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative prediction of microvascular invasion (MVI) in hepatocellular carcinoma based on kupffer phase radiomics features of sonazoid contrast-enhanced ultrasound (SCEUS): A prospective study.
    Dong Y; Zuo D; Qiu YJ; Cao JY; Wang HZ; Yu LY; Wang WP
    Clin Hemorheol Microcirc; 2022; 81(1):97-107. PubMed ID: 35001883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.